References

  1. Centers for Disease Control and Prevention. Condom fact sheet in brief. Cited 2016 Jan 2.

  2. Fleming DT, Wasserhelt JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999 Feb; 75(1):3-17. PubMed | Google Scholar

  3. Baeten JM, Strick LB, Lucchetti A, Whittington WL, Sanchez J, Coombs RW et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis. 2008 Dec 15;198(12):1804-8. PubMed | Google Scholar

  4. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec; 363(27):2587-2599. PubMed | Google Scholar

  5. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double blind, placebo-controlled phase 3 trial. Lancet. 2013 Jun; 381(9883):2083-2090. PubMed | Google Scholar

  6. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012 Aug; 367(5):423-434. PubMed | Google Scholar

  7. Programme nationale multisectoriel de lutte contre le VIH/SIDA (2016) Guide de prise en charge integrée du VIH en République Démocratique du Congo. Available : http://www.pnmls.cd /doc/guide de prise en charge. pdf. Accessed 2017 Sept 10.

  8. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30; 363(27):2587-99. PubMed | Google Scholar

  9. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangsisi J et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 2; 367(5):399-410. PubMed | Google Scholar

  10. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012 Aug 2; 367(5):423-34. PubMed | Google Scholar

  11. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M et al. HIV antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013 Jun 15; 381(9883): 2083-90. PubMed | Google Scholar

  12. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399-410. Google Scholar

  13. Ross I, Mejia C, Melendez J, Chan PA, Nunn AC, Powderly W et al. Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wideimplementation. PLoS ONE. 2017;12(3):e0173057. PubMed | Google Scholar

  14. Tang EC, Sobieszczyk ME, Shu E, Gonzales P, Sanchez J, Lama JR. Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru. AIDS Res Hum Retroviruses. 2014 May; 30(5):416-24. PubMed | Google Scholar

  15. Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013 Oct; 27(10):553-9. PubMed | Google Scholar

  16. Palummieri A, De Carli G, Rosenthal E, Cacoub P, Mussini C, Puro V. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians. BMC Infectious Diseases. 2017 Nov 28;17(1):734. PubMed | Google Scholar

  17. Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K et al. Knowledge is power! Increased provider knowledge scores regarding Pre-exposure Prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015 May;19(5):802-10. PubMed | Google Scholar

  18. Sánchez-Rubio Ferrández J, Martínez Sesmero JM, Navarro Aznárez H, Fernández Espínola S, Escobar Rodríguez I, Ventura Cerdá JM. Perceptions about HIV pre-exposure prophylaxis among healthcare professionals in Spain (PERPPRES Study). Farm Hosp. 2016;40(4):287-301. PubMed | Google Scholar

  19. Sharma M, Wilton J, Senn H, Fowler S, Tan DH. Preparing for PrEP: perceptions and readiness of canadian physicians for the implementation of HIV pre-exposure prophylaxis. PLoS One. 2014;e105283. PubMed | Google Scholar

  20. Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014 Sep;18(9):1712-21. PubMed | Google Scholar

  21. Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention. BMJ. 2006 Mar 11;332(7541):605-7. Google Scholar